NDC 68982-822

Panzyga

Immune Globulin Intravenous (human)

Panzyga is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is Human Immunoglobulin G.

Product ID68982-822_1db52a61-d294-2673-1e73-d47e89ca3d24
NDC68982-822
Product TypePlasma Derivative
Proprietary NamePanzyga
Generic NameImmune Globulin Intravenous (human)
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-11-12
Marketing CategoryBLA /
Application NumberBLA125587
Labeler NameOctapharma USA Inc
Substance NameHUMAN IMMUNOGLOBULIN G
Active Ingredient Strength100 mg/mL
Pharm ClassesHuman Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 68982-822-01

1 BOTTLE, GLASS in 1 CARTON (68982-822-01) > 10 mL in 1 BOTTLE, GLASS (68982-822-81)
Marketing Start Date2018-11-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Panzyga" or generic name "Immune Globulin Intravenous (human)"

NDCBrand NameGeneric Name
0069-1011Panzygaimmune globulin intravenous (human)
0069-1109Panzygaimmune globulin intravenous (human)
0069-1224Panzygaimmune globulin intravenous (human)
0069-1312Panzygaimmune globulin intravenous (human)
0069-1415Panzygaimmune globulin intravenous (human)
0069-1558Panzygaimmune globulin intravenous (human)
68982-820Panzygaimmune globulin intravenous (human)
68982-822Panzygaimmune globulin intravenous (human)
61953-0005FLEBOGAMMA DIFIMMUNE GLOBULIN INTRAVENOUS (HUMAN)
0944-2623GAMMAGARDImmune Globulin Intravenous (Human)
0944-2625GAMMAGARDImmune Globulin Intravenous (Human)
0944-2627GAMMAGARDImmune Globulin Intravenous (Human)
0944-2656GAMMAGARDImmune Globulin Intravenous (Human)
0944-2658GAMMAGARDImmune Globulin Intravenous (Human)

Trademark Results [Panzyga]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PANZYGA
PANZYGA
79148226 4630483 Live/Registered
Octapharma AG
2014-04-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.